Lv5
1040 积分 2026-05-02 加入
Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance
1个月前
已完结
The tumour microenvironment and immune milieu of cholangiocarcinoma
2个月前
已完结
Prognostic impact of tumor microenvironment characteristics in intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
2个月前
已完结
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已完结
Benefit from pemigatinib in cholangiocarcinoma
2个月前
已完结
New Horizons for Precision Medicine in Biliary Tract Cancers
2个月前
已完结
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
2个月前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
New Horizons for Precision Medicine in Biliary Tract Cancers
2个月前
已关闭
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
2个月前
已完结
皖公网安备34019202002308
